IDiyas

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 8772296 B1

PDFFull Text
Date of Patent:
Jul. 08, 2014

Filed:

May. 31, 2007

Benzamide derivatives and uses related thereto

Applicants:

Jay P. Powers, Pacifica, CA (US);

Michael Degraffenreid, San Francisco, CA (US);

Lisa Julian, Redwood City, CA (US);

Jacob Kaizerman, Redwood City, CA (US);

Dustin Mcminn, Pacifica, CA (US);

Yosup Rew, Foster City, CA (US);

Daqing Sun, Foster City, CA (US);

Xuelei Yan, Foster City, CA (US);

Zhulun Wang, Palo Alto, CA (US);

Felix Gonzalez Lopez DE Turiso, San Mateo, CA (US);

Inventors:

Jay P. Powers, Pacifica, CA (US);

Michael Degraffenreid, San Francisco, CA (US);

Lisa Julian, Redwood City, CA (US);

Jacob Kaizerman, Redwood City, CA (US);

Dustin McMinn, Pacifica, CA (US);

Yosup Rew, Foster City, CA (US);

Daqing Sun, Foster City, CA (US);

Xuelei Yan, Foster City, CA (US);

Zhulun Wang, Palo Alto, CA (US);

Felix Gonzalez Lopez De Turiso, San Mateo, CA (US);

Assignee:

Amgen Inc., Thousands Oaks, CA (US);

Attorney:

Elsa D. Lemoine

Primary Examiner:

Kortney L Klinkel

Int. Cl.
CPC ...
A61K 31/166 (2006.01); A61K 31/381 (2006.01); A61K 31/42 (2006.01); A61K 31/426 (2006.01); A61K 31/44 (2006.01); A61K 31/4965 (2006.01); A61K 31/50 (2006.01); A61K 31/505 (2006.01); A61P 3/04 (2006.01); A61P 3/10 (2006.01); C07C 235/42 (2006.01); C07C 271/12 (2006.01); C07D 213/56 (2006.01); C07D 237/08 (2006.01); C07D 239/26 (2006.01); C07D 241/12 (2006.01); C07D 261/08 (2006.01); C07D 277/30 (2006.01); C07D 333/24 (2006.01); C07D 333/38 (2006.01); C07D 277/22 (2006.01); C07C 237/24 (2006.01); C07C 237/42 (2006.01); C07C 237/22 (2006.01); C07C 255/31 (2006.01); C07C 255/46 (2006.01); C07C 271/20 (2006.01); C07C 307/06 (2006.01); C07D 213/30 (2006.01); C07D 213/53 (2006.01);
U.S. Cl.
CPC ...
C07C 235/42 (2013.01); C07D 277/22 (2013.01); C07C 237/24 (2013.01); C07C 237/42 (2013.01); C07C 237/22 (2013.01); C07D 237/08 (2013.01); C07C 255/31 (2013.01); C07C 255/46 (2013.01); C07C 271/12 (2013.01); C07C 271/20 (2013.01); C07C 307/06 (2013.01); C07D 213/30 (2013.01); C07D 213/53 (2013.01); C07D 239/26 (2013.01); C07D 241/12 (2013.01); C07D 261/08 (2013.01); C07C 2101/02 (2013.01); C07C 2101/14 (2013.01); C07C 2103/94 (2013.01); A61K 31/166 (2013.01); A61K 31/381 (2013.01); A61K 31/42 (2013.01); A61K 31/426 (2013.01); A61K 31/44 (2013.01); A61K 31/4965 (2013.01); A61K 31/50 (2013.01); A61K 31/505 (2013.01);
Abstract

Benzamide derivatives of formula I are described and have therapeutic utility, particularly in the treatment of diabetes, obesity and related conditions and disorders: wherein R, R, R, R, R, R, R, R, and n are as defined herein.

Find Patent Forward Citations

Loading…